Article citationsMore>>

Ilumetri (tildrakizumab) (2020) Summary of Product Characteristics. European Medicines Agency.
https://www.ema.europa.eu/en/documents/product-information/ilumetri-epar-product-information_en.pdf

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top